Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
CF Industries Holdings (CF): Can It Reach the Street-High $150 Price Target?

CF Industries Holdings (CF): Can It Reach the Street-High $150 Price Target?

Key Takeaways

  • CF Industries Holdings, Inc. (NYSE: CF) currently trades around $125, and the $150 price target represents the Street-high analyst forecast — about 20% above recent levels and roughly 9% above the stock's all-time high near $138.
  • The strongest bullish argument centers on tight global nitrogen supply, elevated fertilizer prices driven by geopolitical instability, and CF's structural cost advantage from low-cost U.S. natural gas feedstock.
  • The biggest obstacles include a consensus analyst rating of Hold, recent price-target cuts from several major firms, and the inherently cyclical nature of nitrogen fertilizer earnings — with fiscal 2027 EPS expected to decline by roughly 28%.
  • Key technical levels include the all-time high near $138 as major resistance, with psychological support around $100 and the 52-week low near $75.
  • The central takeaway: $150 is achievable under a sustained nitrogen upcycle, but the stock's powerful rally has already priced in considerable optimism, making further gains heavily dependent on continued supply disruptions and crop price strength.

Why the $150 Target Stands Out

Among the 19 to 21 analysts covering CF Industries Holdings, Inc. (CF), the $150 price target stands out as the most bullish call on Wall Street. Wells Fargo analyst Michael Sison reiterated an Overweight rating with this target in May 2026, and firms including Barclays and Freedom Capital Markets have set targets at $145 and $147 respectively — clustering just below the $150 threshold. For investors scanning the analyst landscape, $150 has become shorthand for the bull case, especially after the stock surged roughly 55% year-to-date in 2026 and touched an all-time high of approximately $138 in March.

A Quick Look at CF Industries

CF Industries is the world's largest ammonia producer and a leading global manufacturer of nitrogen-based products. Headquartered in Northbrook, Illinois, the company operates nine world-scale manufacturing complexes across the United States, Canada, and the United Kingdom, producing approximately 10 million tons of ammonia annually. Its product portfolio spans anhydrous ammonia, granular urea, urea ammonium nitrate (UAN), ammonium nitrate, and diesel exhaust fluid. Because CF manufactures nitrogen using low-cost U.S. natural gas as its primary feedstock, it ranks among the lowest-cost nitrogen producers globally — a structural advantage that underpins its profitability during commodity upcycles.

Factors Supporting a Move Higher

Several converging factors support the possibility of CF reaching $150. First, global nitrogen markets remain tight. Ongoing geopolitical tensions — particularly in the Middle East — have disrupted fertilizer supply chains and pushed nitrogen prices higher. Higher crop prices have simultaneously strengthened farmer purchasing power, supporting demand for nitrogen fertilizer during key planting seasons.

Second, CF's financial performance has been exceptional. First-quarter 2026 results showed net sales up 20% and earnings per share (EPS) nearly doubling year-over-year. The full-year 2026 EPS consensus sits at roughly $15.86, approximately 69% above the prior year. The company also announced a 20% dividend increase, signaling management confidence in cash generation.

Third, CF's valuation remains relatively modest. Even after the rally, the stock trades at a trailing price-to-earnings (P/E) ratio of roughly 11x — well below the broader U.S. chemicals industry average of approximately 24x. If nitrogen pricing remains elevated and the market assigns a higher multiple, a move toward $150 becomes mathematically plausible. A discounted cash flow analysis using free cash flow projections has suggested a fair value above $150 in certain scenarios. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Risks That Could Cap Gains

Despite the bullish narrative, significant headwinds could keep $150 out of reach. The most immediate concern is that much of the good news may already be priced in. With the stock up more than 55% year-to-date, the average analyst price target sits near $125 — essentially flat from current levels. Several major firms, including Morgan Stanley, Goldman Sachs, and UBS, trimmed their price targets during mid-2026, and the overall consensus rating across 19-plus analysts remains a cautious Hold.

The cyclical nature of nitrogen fertilizer earnings represents another major risk. While fiscal 2026 EPS is projected at $15.86, consensus estimates for fiscal 2027 point to a sharp decline toward approximately $11.36 — a drop of about 28%. Markets tend to price stocks on forward expectations, and if investors begin discounting a 2027 earnings contraction, the stock could struggle to sustain upward momentum.

An ongoing Department of Justice (DOJ) pricing probe into the fertilizer industry adds regulatory uncertainty. Additionally, any easing of geopolitical tensions or a meaningful decline in natural gas prices in competing regions like Europe or the Middle East could narrow CF's cost advantage and soften nitrogen prices.

Analyst Opinions Remain Mixed

The analyst community is notably split. Wells Fargo and Barclays maintain bullish stances, with targets at $150 and $145 respectively. Freedom Capital Markets upgraded CF to Buy with a $147 target in May 2026. Yet BofA Securities, Mizuho, and Rothschild & Co Redburn sit on the opposite side, with ratings of Underperform or Sell and price targets ranging from $72 to $106. This wide dispersion — from $72 on the low end to $150 on the high end — reflects genuine uncertainty about whether current nitrogen pricing strength can persist beyond the near term. The average target of roughly $125 suggests that, as a group, analysts see the stock as fairly valued at current levels.

Important Technical Levels to Watch

From a technical perspective, CF's all-time high near $138 serves as the most important resistance level. A decisive break above that level — ideally on above-average volume — would likely be required before $150 becomes a realistic near-term objective. On the downside, the $100 level has acted as an important psychological and structural support zone, reinforced by the stock's 52-week low near $75. The stock's rapid ascent from the high $70s to the mid-$130s means the intermediate support zones are less well-defined, which could contribute to heightened volatility during any pullback. From what I see, these levels remain key reference points for any position sizing decisions.

My Take on the Outlook

The question of whether CF Industries can reach $150 hinges on the durability of the current nitrogen upcycle. The bull case — tight global supply, favorable agricultural economics, low-cost U.S. natural gas, and a still-modest P/E multiple — provides a credible pathway to the Street-high target. However, the bear case is equally substantial: a consensus Hold rating, recent analyst downgrades and target cuts, projected earnings contraction in 2027, and a stock that has already absorbed enormous gains. For $150 to materialize, nitrogen prices would likely need to remain elevated well into 2027, geopolitical supply disruptions would need to persist, and the market would need to assign CF a higher earnings multiple than it currently does. Investors should watch nitrogen price trends, crop futures, geopolitical developments, and the DOJ probe as key indicators of whether the rally has further to run.

AI Tools in My Research Process

One resource I turn to when sorting through volatile names and mixed signals is Tickeron’s AI Daily Buy/Sell Signals. The platform applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and evolving market conditions. It helps me quickly cross-check ideas without manually reviewing every chart and report, which keeps the analysis process more efficient when evaluating opportunities like CF.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CF

Aroon Indicator for CF shows an upward move is likely

CF's Aroon Indicator triggered a bullish signal on August 03, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 276 similar instances where the Aroon Indicator showed a similar pattern. In of the 276 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 17, 2026. You may want to consider a long position or call options on CF as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CF just turned positive on August 20, 2026. Looking at past instances where CF's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

CF moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CF advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CF moved out of overbought territory on July 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CF broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CF's P/B Ratio (3.412) is slightly higher than the industry average of (1.518). P/E Ratio (9.614) is within average values for comparable stocks, (44.382). CF's Projected Growth (PEG Ratio) (0.435) is slightly lower than the industry average of (1.249). Dividend Yield (0.016) settles around the average of (0.040) among similar stocks. P/S Ratio (2.618) is also within normal values, averaging (1.482).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 10.16B. The market cap for tickers in the group ranges from 14.68K to 54.57B. CTVA holds the highest valuation in this group at 54.57B. The lowest valued company is CGSI at 14.68K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was 4%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -8%. MOS experienced the highest price growth at 13%, while NXTS experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 99%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 58
Price Growth Rating: 54
SMR Rating: 81
Profit Risk Rating: 79
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
CF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of nitrogen fertilizer products

Industry ChemicalsAgricultural

Profile
Details
Industry
Chemicals Agricultural
Address
2375 Waterview Drive
Phone
+1 847 405-2400
Employees
2700
Web
https://www.cfindustries.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
CF Industries Holdings (CF): Can It Reach the Street-High $150 Price Target?